Cargando…
Activity-based protein profiling reveals deubiquitinase and aldehyde dehydrogenase targets of a cyanopyrrolidine probe
Ubiquitin carboxy-terminal hydrolase L1 (UCHL1), a deubiquitinating enzyme (DUB), is a potential drug target in various cancers, and liver and lung fibrosis. However, bona fide functions and substrates of UCHL1 remain poorly understood. Herein, we report the characterization of UCHL1 covalent inhibi...
Autores principales: | Panyain, Nattawadee, Godinat, Aurélien, Thawani, Aditya Raymond, Lachiondo-Ortega, Sofía, Mason, Katie, Elkhalifa, Sarah, Smith, Lisa M., Harrigan, Jeanine A., Tate, Edward W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
RSC
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8597422/ https://www.ncbi.nlm.nih.gov/pubmed/34820624 http://dx.doi.org/10.1039/d1md00218j |
Ejemplares similares
-
Discovery
of a Potent and Selective Covalent Inhibitor
and Activity-Based Probe for the Deubiquitylating Enzyme UCHL1, with
Antifibrotic Activity
por: Panyain, Nattawadee, et al.
Publicado: (2020) -
Correction to “Discovery of a Potent and Selective
Covalent Inhibitor and Activity-Based Probe for the Deubiquitylating
Enzyme UCHL1, with Antifibrotic Activity”
por: Panyain, Nattawadee, et al.
Publicado: (2020) -
Therapeutic Effect of Novel Cyanopyrrolidine-Based Prolyl Oligopeptidase Inhibitors in Rat Models of Amnesia
por: Zolotov, Nikolay N., et al.
Publicado: (2021) -
Two clinical drugs deubiquitinase inhibitor auranofin and aldehyde dehydrogenase inhibitor disulfiram trigger synergistic anti-tumor effects in vitro and in vivo
por: Huang, Hongbiao, et al.
Publicado: (2015) -
Alcohol dehydrogenase and aldehyde dehydrogenase in malignant neoplasms
por: Orywal, Karolina, et al.
Publicado: (2016)